Literature DB >> 3279793

Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc.

H S Friedman1, P C Burger, S H Bigner, J Q Trojanowski, G M Brodeur, X M He, C J Wikstrand, J Kurtzberg, M E Berens, E C Halperin.   

Abstract

D341 Med is a new continuous cell line and transplantable xenograft derived from a cerebellar medulloblastoma. This line grew in vitro in suspension culture with spontaneous macroscopic spheroid formation and demonstrated 20-fold amplification of c-myc. Cultured D341 Med cells injected subcutaneously into athymic mice grew as markedly cellular, highly invasive undifferentiated neoplasms. Intracranial tumors grew as markedly cellular mitotically active neoplasms largely located within the subarachnoid space or lining the ventricular system. Immunocytochemical analysis of the cell line and SQ tumors revealed the high (NFP-H) and middle (NFP-M) molecular weight (Mr) neurofilament proteins (NFPs). Immunoblots demonstrated the presence of molecular species that co-migrated with authentic human NFP-H and NFP-M. This cell line and transplantable xenograft may allow, in conjunction with the authors' other models of human medulloblastoma, analysis of the heterogeneous biologic properties and therapeutic sensitivity of this tumor.

Entities:  

Mesh:

Year:  1988        PMID: 3279793      PMCID: PMC1880676     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  49 in total

1.  Simple and rapid fluorimetric method for DNA microassay.

Authors:  J Kapuściński; B Skoczylas
Journal:  Anal Biochem       Date:  1977-11       Impact factor: 3.365

2.  Heterotransplantation of human craniopharyngiomas in athymic "nude" mice.

Authors:  D E Bullard; D D Bigner
Journal:  Neurosurgery       Date:  1979-04       Impact factor: 4.654

3.  Expression of human fetal brain antigens by human tumors of neuroectodermal origin as defined by monoclonal antibodies.

Authors:  C J Wikstrand; D D Bigner
Journal:  Cancer Res       Date:  1982-01       Impact factor: 12.701

Review 4.  Medulloblastoma in children: increasing survival rates and further prospects.

Authors:  H J Bloom
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-11       Impact factor: 7.038

5.  Isolation and characterization of the nervous system-specific protein 14-3-2 from rat brain. Purification, subunit composition, and comparison to the beef brain protein.

Authors:  P J Marangos; C Zomzely-Neurath; D C Luk; C York
Journal:  J Biol Chem       Date:  1975-03-10       Impact factor: 5.157

6.  The role of glutamine synthetase in the diagnosis of cerebral tumours.

Authors:  G J Pilkington; P L Lantos
Journal:  Neuropathol Appl Neurobiol       Date:  1982 May-Jun       Impact factor: 8.090

7.  Astrocytic differentiation in medulloblastoma.

Authors:  R O Barnard; H Pambakian
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-11       Impact factor: 10.154

8.  Surface antigenic characteristics of human glial brain tumor cells.

Authors:  C J Wikstrand; M S Mahaley; D D Bigner
Journal:  Cancer Res       Date:  1977-12       Impact factor: 12.701

9.  Heterogeneity of Genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas.

Authors:  D D Bigner; S H Bigner; J Pontén; B Westermark; M S Mahaley; E Ruoslahti; H Herschman; L F Eng; C J Wikstrand
Journal:  J Neuropathol Exp Neurol       Date:  1981-05       Impact factor: 3.685

10.  Neuron-specific enolase and neurofilament protein as markers of differentiation in medulloblastoma.

Authors:  M E Velasco; M W Ghobrial; E R Ross
Journal:  Surg Neurol       Date:  1985-02
View more
  45 in total

1.  Nerve growth factor receptor expression in peripheral and central neuroectodermal tumors, other pediatric brain tumors, and during development of the adrenal gland.

Authors:  D L Baker; W M Molenaar; J Q Trojanowski; A E Evans; A H Ross; L B Rorke; R J Packer; V M Lee; D Pleasure
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

2.  The gene expression profiles of medulloblastoma cell lines resistant to preactivated cyclophosphamide.

Authors:  M D Bacolod; S M Lin; S P Johnson; N S Bullock; M Colvin; D D Bigner; H S Friedman
Journal:  Curr Cancer Drug Targets       Date:  2008-05       Impact factor: 3.428

3.  Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma.

Authors:  Matija Snuderl; Ana Batista; Nathaniel D Kirkpatrick; Carmen Ruiz de Almodovar; Lars Riedemann; Elisa C Walsh; Rachel Anolik; Yuhui Huang; John D Martin; Walid Kamoun; Ellen Knevels; Thomas Schmidt; Christian T Farrar; Benjamin J Vakoc; Nishant Mohan; Euiheon Chung; Sylvie Roberge; Teresa Peterson; Carlos Bais; Boryana H Zhelyazkova; Stephen Yip; Martin Hasselblatt; Claudia Rossig; Elisabeth Niemeyer; Napoleone Ferrara; Michael Klagsbrun; Dan G Duda; Dai Fukumura; Lei Xu; Peter Carmeliet; Rakesh K Jain
Journal:  Cell       Date:  2013-02-28       Impact factor: 41.582

Review 4.  Cellular and molecular pathology of medulloblastoma.

Authors:  J P Provias; L E Becker
Journal:  J Neurooncol       Date:  1996-07       Impact factor: 4.130

5.  Effects of basic fibroblastic growth factor on the growth of human medulloblastoma xenografts.

Authors:  Pascal Vachon; Christiane Girard; Yves Théorêt
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

Review 6.  Genetic alterations in glioma and medulloblastoma.

Authors:  B K Rasheed; S H Bigner
Journal:  Cancer Metastasis Rev       Date:  1991-12       Impact factor: 9.264

7.  p53 protein expression in central nervous system tumors: an immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodies.

Authors:  E Karamitopoulou; E Perentes; I Diamantis
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

8.  Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas.

Authors:  D C Longee; C J Wikstrand; J E Månsson; X He; G N Fuller; S H Bigner; P Fredman; L Svennerholm; D D Bigner
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

9.  Molecular characterization of the pediatric preclinical testing panel.

Authors:  Geoffrey Neale; Xiaoping Su; Christopher L Morton; Doris Phelps; Richard Gorlick; Richard B Lock; C Patrick Reynolds; John M Maris; Henry S Friedman; Jeffrey Dome; Joseph Khoury; Timothy J Triche; Robert C Seeger; Richard Gilbertson; Javed Khan; Malcolm A Smith; Peter J Houghton
Journal:  Clin Cancer Res       Date:  2008-07-15       Impact factor: 12.531

Review 10.  Cyclophosphamide therapy of medulloblastoma: from the laboratory to the clinic and back again (and again and again).

Authors:  H S Friedman; S H Bigner; D D Bigner
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.